A proposal for a comprehensive approach to infections across the surgical pathway

[1]  A. Branche,et al.  How to: implement procalcitonin testing in my practice. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  D. Cardo,et al.  Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1) , 2019, Antimicrobial Resistance & Infection Control.

[3]  K. Itani,et al.  2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients , 2019, World Journal of Emergency Surgery.

[4]  J. D. De Waele,et al.  Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient , 2019, Expert review of anti-infective therapy.

[5]  M. Kollef,et al.  Rationalizing antimicrobial therapy in the ICU: a narrative review , 2019, Intensive Care Medicine.

[6]  K. Mertens,et al.  Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis , 2019, The Lancet. Infectious diseases.

[7]  B. Allegranzi,et al.  Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Judy McKimm,et al.  Health care-associated infections – an overview , 2018, Infection and drug resistance.

[9]  H. Sax,et al.  The preventable proportion of healthcare-associated infections 2005–2016: Systematic review and meta-analysis , 2018, Infection Control & Hospital Epidemiology.

[10]  R. Ben-Ami.  Treatment of Invasive Candidiasis: A Narrative Review , 2018, Journal of fungi.

[11]  E. Bouza,et al.  Role of the Clinical Microbiology Laboratory in Antimicrobial Stewardship. , 2018, The Medical clinics of North America.

[12]  E. Burnett.  Effective infection prevention and control: the nurse's role. , 2018, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[13]  S. Berenholtz,et al.  A multimodal infection control and patient safety intervention to reduce surgical site infections in Africa: a multicentre, before-after, cohort study. , 2018, The Lancet. Infectious diseases.

[14]  P. Collignon,et al.  Antimicrobial Resistance: a One Health Perspective. , 2018, Microbiology spectrum.

[15]  J. Schrenzel,et al.  Control of Infectious Diseases in the Era of European Clinical Microbiology Laboratory Consolidation: New Challenges and Opportunities for the Patient and for Public Health Surveillance , 2018, Front. Med..

[16]  M. Boermeester,et al.  A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway. , 2017, Surgical infections.

[17]  P. Póvoa,et al.  Biomarker-guided antibiotic therapy-strengths and limitations. , 2017, Annals of translational medicine.

[18]  B. Allegranzi,et al.  The Effect of Participating in a Surgical Site Infection (SSI) Surveillance Network on the Time Trend of SSI Rates: A Systematic Review , 2017, Infection Control & Hospital Epidemiology.

[19]  K. Itani,et al.  Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017 , 2017, JAMA surgery.

[20]  M. Catani,et al.  The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship—results from an international cross-sectional survey , 2017, World Journal of Emergency Surgery.

[21]  M. Boermeester,et al.  Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference , 2017, World Journal of Emergency Surgery.

[22]  L. Kao,et al.  Patients at High-Risk for Surgical Site Infection. , 2017, Surgical infections.

[23]  Alan E. Jones,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[24]  R. Kullar,et al.  A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. , 2017, The Lancet. Infectious diseases.

[25]  J. Bartlett.  Bezlotoxumab - A New Agent for Clostridium difficile Infection. , 2017, The New England journal of medicine.

[26]  M. Egger,et al.  Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations , 2017, Antimicrobial Resistance & Infection Control.

[27]  C. Feldman,et al.  From guidelines to practice: a pharmacist-driven prospective audit and feedback improvement model for peri-operative antibiotic prophylaxis in 34 South African hospitals , 2016, The Journal of antimicrobial chemotherapy.

[28]  J. Dumville,et al.  Dressings for the prevention of surgical site infection. , 2016, The Cochrane database of systematic reviews.

[29]  Mohamed Abbas,et al.  New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. , 2016, The Lancet. Infectious diseases.

[30]  Mohamed Abbas,et al.  Surgical site infections 2 New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective , 2016 .

[31]  H. Park,et al.  Impact of monitoring surgical prophylactic antibiotics and a computerized decision support system on antimicrobial use and antimicrobial resistance. , 2016, American journal of infection control.

[32]  D. Heyland,et al.  Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial. , 2016, JAMA internal medicine.

[33]  M. Antonelli,et al.  (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study. , 2016, The Journal of antimicrobial chemotherapy.

[34]  SartelliMassimo,et al.  Non-Restrictive Antimicrobial Stewardship Program in a General and Emergency Surgery Unit. , 2016 .

[35]  M. Boermeester,et al.  Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA) , 2016, World Journal of Emergency Surgery.

[36]  Tom Dormans,et al.  Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. , 2016, The Lancet. Infectious diseases.

[37]  N. Shafiq,et al.  Antibiotic stewardship in a tertiary care hospital of a developing country: establishment of a system and its application in a unit—GASP Initiative , 2016, Infection.

[38]  J. Timsit,et al.  A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  P. Montravers,et al.  Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections , 2016, Critical Care.

[40]  Robert R Cima,et al.  Failure of Colorectal Surgical Site Infection Predictive Models Applied to an Independent Dataset: Do They Add Value or Just Confusion? , 2016, Journal of the American College of Surgeons.

[41]  M. Edye,et al.  Educational Antimicrobial Stewardship Intervention Ineffective in Changing Surgical Prophylactic Antibiotic Prescribing. , 2016, Surgical infections.

[42]  G. Greub,et al.  Laboratory automation in clinical bacteriology: what system to choose? , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[43]  C. Porucznik.  Preventing Hospital Infections: Real-World Problems, Realistic Solutions , 2015, Care Management Journals.

[44]  G. Raman,et al.  Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis , 2015, BMC Infectious Diseases.

[45]  E. Moore,et al.  The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper , 2015, World Journal of Emergency Surgery.

[46]  M. Çakmakçı,et al.  Long-term sustainability of zero central-line associated bloodstream infections is possible with high compliance with care bundle elements. , 2015, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[47]  F. Gilsanz,et al.  Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study. , 2015, Journal of critical care.

[48]  P. Lipsett,et al.  Trial of short-course antimicrobial therapy for intraabdominal infection. , 2015, The New England journal of medicine.

[49]  M. Çakmakçı.  Antibiotic stewardship programmes and the surgeon's role. , 2015, The Journal of hospital infection.

[50]  R. Fagan,et al.  Surgical Site Infection Risk Factors and Risk Stratification , 2015, The Journal of the American Academy of Orthopaedic Surgeons.

[51]  C. Waters.  Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support. , 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[52]  N. Orford,et al.  Effectiveness of a care bundle to reduce central line‐associated bloodstream infections , 2015, The Medical journal of Australia.

[53]  E. Kavanagh,et al.  Improving surgical site infection prevention practices through a multifaceted educational intervention. , 2015, Irish medical journal.

[54]  P. Malani,et al.  Diagnosis and treatment of Clostridium difficile in adults: a systematic review. , 2015, JAMA.

[55]  Edward H. Eiland,et al.  Fidaxomicin Use and Clinical Outcomes for Clostridium difficile–Associated Diarrhea , 2014, Infectious diseases in clinical practice.

[56]  L. Miller,et al.  Risk Factors for Central Line–Associated Bloodstream Infections in the Era of Prevention Bundles , 2014, Infection Control & Hospital Epidemiology.

[57]  A. Hrõbjartsson,et al.  Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. , 2014, The Cochrane database of systematic reviews.

[58]  S. Saint,et al.  Preventing Hospital Infections: Real-World Problems, Realistic Solutions , 2014 .

[59]  K. Bauer,et al.  An Antimicrobial Stewardship Program's Real‐World Experience with Fidaxomicin for Treatment of Clostridium difficile Infection: A Case Series , 2014, Pharmacotherapy.

[60]  A. Friedrich,et al.  Important issues for perioperative systemic antimicrobial prophylaxis in surgery , 2014, Current opinion in anaesthesiology.

[61]  S. Msika,et al.  Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial. , 2014, JAMA.

[62]  A. Pan,et al.  The Italian national surgical site infection surveillance programme and its positive impact, 2009 to 2011. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[63]  T. Louie,et al.  Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  A. Morris.  Antimicrobial Stewardship Programs: Appropriate Measures and Metrics to Study their Impact , 2014, Current Treatment Options in Infectious Diseases.

[65]  T. Riley,et al.  Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. , 2014, The Journal of antimicrobial chemotherapy.

[66]  M. Bassetti,et al.  An Italian consensus for invasive candidiasis management (ITALIC) , 2014, Infection.

[67]  J. Edwards,et al.  National and state healthcare-associated infections progress report , 2014 .

[68]  Ting-Shuo Huang,et al.  A Procalcitonin-Based Algorithm to Guide Antibiotic Therapy in Secondary Peritonitis following Emergency Surgery: A Prospective Study with Propensity Score Matching Analysis , 2014, PloS one.

[69]  M. P. Bauer,et al.  European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[70]  Jung-Hyun Choi,et al.  Biomarkers of Sepsis , 2014, Infection & chemotherapy.

[71]  M. Bassetti,et al.  An Italian consensus for invasive candidiasis management (ITALIC) , 2014, Infection.

[72]  G. Bearman,et al.  Surgeons Do Not Listen: Evaluation of Compliance with Antimicrobial Stewardship Program Recommendations , 2013, The American surgeon.

[73]  V. Nobre,et al.  Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in Sepsis: A Randomized Trial* , 2013, Critical care medicine.

[74]  A. Oliver,et al.  Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance. , 2013, Enfermedades infecciosas y microbiologia clinica.

[75]  A. Marra,et al.  Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. , 2013, Diagnostic microbiology and infectious disease.

[76]  Mervyn Singer,et al.  Biomarkers in sepsis , 2013, Current Opinion in Pulmonary Medicine.

[77]  M. Exline,et al.  Beyond the bundle - journey of a tertiary care medical intensive care unit to zero central line-associated bloodstream infections , 2013, Critical Care.

[78]  D. Annane,et al.  Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial , 2013, BMJ Open.

[79]  E. P. Dellinger,et al.  Clinical practice guidelines for antimicrobial prophylaxis in surgery. , 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[80]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[81]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[82]  D. Ledoux,et al.  Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients* , 2012, Critical care medicine.

[83]  P. Póvoa,et al.  Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review , 2012, Annals of Intensive Care.

[84]  R. Cavallazzi,et al.  Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis , 2012, The American Journal of Gastroenterology.

[85]  J. Robert,et al.  Point prevalence survey of antibiotic use in French hospitals in 2009. , 2012, The Journal of antimicrobial chemotherapy.

[86]  D. Crook,et al.  Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. , 2012, The Lancet. Infectious diseases.

[87]  I. Mizrahi,et al.  Role of Antibiotic Therapy in Mild Acute Calculus Cholecystitis: A Prospective Randomized Controlled Trial , 2012, World Journal of Surgery.

[88]  L. McDonald,et al.  Infection control in the multidrug-resistant era: tending the human microbiome. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[89]  J. Bakken,et al.  Treating Clostridium difficile infection with fecal microbiota transplantation. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[90]  J. Kline,et al.  Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol* , 2011, Critical care medicine.

[91]  S. Schroeder,et al.  [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients]. , 2011, Der Anaesthesist.

[92]  S. Nielsen,et al.  Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia , 2011, Journal of Clinical Microbiology.

[93]  M. Falagas,et al.  β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[94]  J. Marshall,et al.  Principles of source control in the management of sepsis. , 2011, Critical care nursing clinics of North America.

[95]  Pamela Sears,et al.  Fidaxomicin versus vancomycin for Clostridium difficile infection. , 2011, The New England journal of medicine.

[96]  T. Calandra,et al.  The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia , 2010, Critical care.

[97]  Leonard Leibovici,et al.  Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis , 2010, Antimicrobial Agents and Chemotherapy.

[98]  E. Anaissie,et al.  Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[99]  J. Marshall,et al.  Principles of Source Control in the Early Management of Sepsis , 2010, Current infectious disease reports.

[100]  Javier Llorca,et al.  Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study* , 2010, Critical care medicine.

[101]  M. Sartelli.  A focus on intra-abdominal infections , 2010, World journal of emergency surgery : WJES.

[102]  X. Castells,et al.  Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case–control study , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[103]  F. Tubach,et al.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial , 2010, The Lancet.

[104]  H. Goossens,et al.  The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[105]  Ricard Ferrer,et al.  Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. , 2009, American journal of respiratory and critical care medicine.

[106]  J. Marshall,et al.  Principles of source control in the management of sepsis. , 2009, Critical care clinics.

[107]  D. Candinas,et al.  Impact of intraoperative behavior on surgical site infections. , 2009, American journal of surgery.

[108]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[109]  B. Bein,et al.  Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial , 2009, Critical care.

[110]  Kerenza Hood,et al.  Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial , 2009, BMJ : British Medical Journal.

[111]  R. Lilford,et al.  Is Antibiotic Prophylaxis in Surgery a Generally Effective Intervention?: Testing a Generic Hypothesis Over a Set of Meta-Analyses , 2009, Annals of surgery.

[112]  H. Evans,et al.  Choosing antibiotics for intra-abdominal infections: what do we mean by "high risk"? , 2009, Surgical infections.

[113]  B. Bein,et al.  Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study , 2009, Langenbeck's Archives of Surgery.

[114]  C. Donskey,et al.  Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[115]  J. Bartlett.  The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[116]  J. Pugin,et al.  Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. , 2008, American journal of respiratory and critical care medicine.

[117]  Carlene A. Muto,et al.  Antimicrobial-associated risk factors for Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[118]  D. Gouma,et al.  Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. , 2007, JAMA.

[119]  Melinda B Davis,et al.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[120]  J. Wille,et al.  Associations Between Surgical Site Infection Risk and Hospital Operation Volume and Surgeon Operation Volume Among Hospitals in the Dutch Nosocomial Infection Surveillance Network , 2007, Infection Control & Hospital Epidemiology.

[121]  J. Beney,et al.  Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review , 2007, Pharmacy World & Science.

[122]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[123]  J. Garnacho-Montero,et al.  A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization* , 2006, Critical care medicine.

[124]  N. Nagelkerke,et al.  Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis. , 2005, The Journal of antimicrobial chemotherapy.

[125]  J. Berlin,et al.  The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[126]  F. Kallehave,et al.  Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. , 2005, The Cochrane database of systematic reviews.

[127]  D. DeLong,et al.  Practice patterns in percutaneous image-guided intraabdominal abscess drainage: survey of academic and private practice centers. , 2004, Radiology.

[128]  B. Guidet,et al.  Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. , 2002, Journal of critical care.

[129]  D. Pardi,et al.  Clostridium difficile-associated diarrhea and colitis. , 2001, Mayo Clinic proceedings.

[130]  H. Dashti,et al.  Would measurement of C-reactive protein reduce the rate of negative exploration for acute appendicitis? , 2000, Journal of the Royal College of Surgeons of Edinburgh.

[131]  R. Gaynes,et al.  Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[132]  D. Dean,et al.  Surgical Perspective on Invasive Candida Infections , 1998, World Journal of Surgery.

[133]  G. Gurleyik,et al.  Accuracy of serum c-reactive protein measurements in diagnosis of acute appendicitis compared with surgeon's clinical impression , 1995, Diseases of the colon and rectum.

[134]  J. L. Gray,et al.  Antimicrobial misuse in patients with positive blood cultures. , 1989, The American journal of medicine.

[135]  D. Gerding,et al.  PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS , 1983, The Lancet.

[136]  D. van Duin,et al.  Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria. , 2019, F1000Research.

[137]  A. Chiodera,et al.  Non-Restrictive Antimicrobial Stewardship Program in a General and Emergency Surgery Unit. , 2016, Surgical infections.

[138]  T. A. Gray,et al.  Dressings for the prevention of surgical site infection. , 2016, The Cochrane database of systematic reviews.

[139]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[140]  D. Osmon,et al.  Antimicrobial prophylaxis in adults. , 2011, Mayo Clinic proceedings.

[141]  A. Soyder,et al.  Peri-operative antibiotic prophylaxis: adherence to guidelines and effects of educational intervention. , 2010, International journal of surgery.

[142]  P. Baker,et al.  Framework for action on interprofessional education and collaborative practice , 2010 .

[143]  H. Shakhatreh.  The accuracy of C-reactive protein in the diagnosis of acute appendicitis compared with that of clinical diagnosis. , 2000, Medicinski arhiv.

[144]  Shakhatreh Hs.  The accuracy of C-reactive protein in the diagnosis of acute appendicitis compared with that of clinical diagnosis. , 2000 .

[145]  J. Silva,et al.  Treatment of antibiotic-associated colitis with vancomycin. , 1984, The Journal of antimicrobial chemotherapy.

[146]  D. Istance.  Organization for Economic Co-operation and Development , 1966, Nature.